Literature DB >> 25316829

Introduction of sequential inactivated polio vaccine-oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program.

Carla Magda Allan S Domingues1, Sirlene de Fátima Pereira2, Ana Carolina Cunha Marreiros2, Nair Menezes2, Brendan Flannery3.   

Abstract

In August 2012, the Brazilian Ministry of Health introduced inactivated polio vaccine (IPV) as part of sequential polio vaccination schedule for all infants beginning their primary vaccination series. The revised childhood immunization schedule included 2 doses of IPV at 2 and 4 months of age followed by 2 doses of oral polio vaccine (OPV) at 6 and 15 months of age. One annual national polio immunization day was maintained to provide OPV to all children aged 6 to 59 months. The decision to introduce IPV was based on preventing rare cases of vaccine-associated paralytic polio, financially sustaining IPV introduction, ensuring equitable access to IPV, and preparing for future OPV cessation following global eradication. Introducing IPV during a national multivaccination campaign led to rapid uptake, despite challenges with local vaccine supply due to high wastage rates. Continuous monitoring is required to achieve high coverage with the sequential polio vaccine schedule. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Brazil; acute flaccid paralysis; inactivated polio vaccine; poliomyelitis; vaccination schedule

Mesh:

Substances:

Year:  2014        PMID: 25316829      PMCID: PMC4758462          DOI: 10.1093/infdis/jit588

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  26 in total

Review 1.  Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review.

Authors:  P A Patriarca; P F Wright; T J John
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct

Review 2.  National immunization days: experience in Latin America.

Authors:  J M Olivé; J B Risi; C A de Quadros
Journal:  J Infect Dis       Date:  1997-02       Impact factor: 5.226

3.  Antipoliomyelitis program in Brazil; a erologic study of immunity levels.

Authors:  N C de Brito Bastos; E S Carvalho Filho ES de+CARVALHOAAFILHO; H Schatzmayr; A Homma; J Chaves
Journal:  Bull Pan Am Health Organ       Date:  1974

4.  The control of poliomyelitis in Brazil.

Authors:  J Baptista Risi
Journal:  Rev Infect Dis       Date:  1984 May-Jun

5.  Serological evaluation of poliomyelitis oral and inactivated vaccines in an urban low-income population at Rio de Janeiro, Brazil.

Authors:  H G Schatzmayr; Y Maurice; M Fujita; A M de Fillipis
Journal:  Vaccine       Date:  1986-06       Impact factor: 3.641

6.  Vaccine-associated paralytic poliomyelitis: a retrospective cohort study of acute flaccid paralyses in Brazil.

Authors:  L H de Oliveira; C J Struchiner
Journal:  Int J Epidemiol       Date:  2000-08       Impact factor: 7.196

7.  [The occurrence of vaccine-associated paralytic poliomyelitis in Brazil, 1995 to 2001].

Authors:  Eduardo Souza Teixeira-Rocha; Eduardo Hage Carmo; José Tavares-Neto
Journal:  Rev Panam Salud Publica       Date:  2005-07

8.  Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.

Authors:  J K Andrus; P M Strebel; C A de Quadros; J M Olivé
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

9.  Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine.

Authors: 
Journal:  J Infect Dis       Date:  1995-05       Impact factor: 5.226

10.  Randomised trial of alternative formulations of oral poliovaccine in Brazil.

Authors:  P A Patriarca; F Laender; G Palmeira; M J Oliveira; J Lima Filho; M C Dantes; M T Cordeiro; J B Risi; W A Orenstein
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

View more
  8 in total

1.  Acute flaccid paralysis laboratorial surveillance in a polio-free country: Brazil, 2005-2014.

Authors:  Ivanildo P Sousa; Fernanda M Burlandy; Silas S Oliveira; Amanda M Nunes; Cristiane Sousa; Elaine M da Silva; Jaqueline G A Souza; Valdemar A de Paula; Ivone C M Oliveira; Fernando Neto Tavares; Eliane V da Costa; Edson Elias da Silva
Journal:  Hum Vaccin Immunother       Date:  2016-11-30       Impact factor: 3.452

Review 2.  Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems.

Authors:  Xueting Wang; Ning Wang; Ning Li; Yuanyuan Zhen; Ting Wang
Journal:  Hum Vaccin Immunother       Date:  2016-05-09       Impact factor: 3.452

3.  Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.

Authors:  Agustín Ciapponi; Ariel Bardach; Lucila Rey Ares; Demián Glujovsky; María Luisa Cafferata; Silvana Cesaroni; Aikant Bhatti
Journal:  Cochrane Database Syst Rev       Date:  2019-12-05

4.  Low Rates of Poliovirus Antibodies in Primary Immunodeficiency Patients on Regular Intravenous Immunoglobulin Treatment.

Authors:  Beatriz T Costa-Carvalho; Kathleen E Sullivan; Patrícia M Fontes; Fernanda Aimé-Nobre; Isabela G S Gonzales; Elaine S Lima; Celso Granato; Maria Isabel de Moraes-Pinto
Journal:  J Clin Immunol       Date:  2018-07-14       Impact factor: 8.317

5.  Lessons Learned From Managing the Planning and Implementation of Inactivated Polio Vaccine Introduction in Support of the Polio Endgame.

Authors:  Simona Zipursky; Manish Patel; Margaret Farrell; Alejandro Ramirez Gonzalez; Tasleem Kachra; Yann Folly; Feyrouz Kurji; Chantal Laroche Veira; Emily Wootton; Lee M Hampton
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

6.  Assessing Inactivated Polio Vaccine Introduction and Utilization in Kano State, Nigeria, April-November 2015.

Authors:  Lynda U Osadebe; Adam MacNeil; Hashim Elmousaad; Lora Davis; Jibrin M Idris; Suleiman A Haladu; Olorunsogo B Adeoye; Patrick Nguku; Uneratu Aliu-Mamudu; Elizabeth Hassan; John Vertefeuille; Peter Bloland
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

Review 7.  Administering Multiple Injectable Vaccines During a Single Visit-Summary of Findings From the Accelerated Introduction of Inactivated Polio Vaccine Globally.

Authors:  Samantha B Dolan; Manish Patel; Lee M Hampton; Eleanor Burnett; Daniel C Ehlman; Julie Garon; Emily Cloessner; Elizabeth Chmielewski; Terri B Hyde; Carsten Mantel; Aaron S Wallace
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  Cost-effectiveness of various immunization schedules with inactivated Sabin strain polio vaccine in Hangzhou, China.

Authors:  Yuyang Xu; Yan Liu; Jun Wang; Xinren Che; Jian Du; Xiaoping Zhang; Wenwen Gu; Xuechao Zhang; Wei Jiang
Journal:  Front Public Health       Date:  2022-09-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.